New details about Plymouth Meeting firm’s IPO plans reveal value could approach $107M
August 14, 2020 at 13:16 PM EDT
The biopharmaceutical company set a per-share price range between $20 and $23 for its initial public offering.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|